Biomarkers for the identification of recurrence in human epidermal growth factor receptor 2-positive breast cancer patients.

Abstract

PURPOSE OF REVIEW This review discusses the mechanisms of anti-human epidermal growth factor receptor 2 (HER2) resistance in breast cancer patients, detailing possible predictive biomarkers of therapy benefit that could implement novel therapeutic strategies. RECENT FINDINGS Despite a remarkable improvement in survival over the past two decades, up to 30… (More)

Topics

Cite this paper

@article{Pruneri2016BiomarkersFT, title={Biomarkers for the identification of recurrence in human epidermal growth factor receptor 2-positive breast cancer patients.}, author={Giancarlo Pruneri and Giuseppina Bonizzi and Andrea Vingiani}, journal={Current opinion in oncology}, year={2016}, volume={28 6}, pages={476-483} }